140 related articles for article (PubMed ID: 24777039)
21. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
Al-Hendy A; Salama SA
J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
[TBL] [Abstract][Full Text] [Related]
22. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids.
de Oliveira E; de Aquino Castro R; Gomes MT; da Silva ID; Baracat EC; de Lima GR; Sartori MG; Girão MJ
Maturitas; 2008; 60(3-4):235-8. PubMed ID: 18752908
[TBL] [Abstract][Full Text] [Related]
23. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
24. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
[TBL] [Abstract][Full Text] [Related]
25. Association of polymorphisms and haplotypes in the cytochrome P450 1B1 gene with uterine leiomyoma: A case control study.
Salimi S; Khodamian M; Narooie-Nejad M; Hajizadeh A; Fazeli K; Namazi L; Yaghmaei M
Biomed Rep; 2015 Mar; 3(2):201-206. PubMed ID: 26075073
[TBL] [Abstract][Full Text] [Related]
26. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study.
Moreno-Galván M; Herrera-González NE; Robles-Pérez V; Velasco-Rodríguez JC; Tapia-Conyer R; Sarti E
Int J Biol Markers; 2010; 25(3):157-63. PubMed ID: 20878621
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
Ghisari M; Eiberg H; Long M; Bonefeld-Jørgensen EC
Environ Health; 2014 Mar; 13(1):19. PubMed ID: 24629213
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
30. African ancestry and genetic risk for uterine leiomyomata.
Wise LA; Ruiz-Narvaez EA; Palmer JR; Cozier YC; Tandon A; Patterson N; Radin RG; Rosenberg L; Reich D
Am J Epidemiol; 2012 Dec; 176(12):1159-68. PubMed ID: 23161897
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
[TBL] [Abstract][Full Text] [Related]
32. Association of HOTAIR gene polymorphisms and haplotypes with uterine leiomyoma susceptibility in southeast of Iran.
Farzaneh F; Saravani M; Esmailpoor M; Mokhtari M; Teimoori B; Rezaei M; Salimi S
Mol Biol Rep; 2019 Aug; 46(4):4271-4277. PubMed ID: 31119441
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
34. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.
Yoon KA; Kim JH; Gil HJ; Hwang H; Hwangbo B; Lee JS
Lung Cancer; 2008 Apr; 60(1):40-46. PubMed ID: 17980933
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
36. The role of MSP I CYP1A1 gene polymorphism in the development of uterine fibroids.
Barão MA; Oliveira E; Gomes MT; da Silva ID; Sartori MG; Girão MJ; Castro Rde A
Fertil Steril; 2010 Dec; 94(7):2783-5. PubMed ID: 20579990
[TBL] [Abstract][Full Text] [Related]
37. Association between COMT Val158Met polymorphism and preeclampsia in the Chinese Han population.
Zhao X; Liu J; Zhao C; Ye P; Ji J; Wang J; Song W; Xu J; Liu S
Hypertens Pregnancy; 2016 Nov; 35(4):565-572. PubMed ID: 27646972
[TBL] [Abstract][Full Text] [Related]
38. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
39. Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions.
Huber A; Keck CC; Hefler LA; Schneeberger C; Huber JC; Bentz EK; Tempfer CB
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1025-31. PubMed ID: 16260521
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect.
Su MT; Chen CH; Kuo PH; Hsu CC; Lee IW; Pan HA; Chen YT; Kuo PL
Fertil Steril; 2010 Jan; 93(1):141-9. PubMed ID: 18980759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
